PortalPublikationenVie Scope® versus videolaryngoscopy in expected difficult ai...

Vie Scope® versus videolaryngoscopy in expected difficult airways: a randomized controlled trial

Standard

Vie Scope® versus videolaryngoscopy in expected difficult airways: a randomized controlled trial. / Petzoldt, Martin; Grün, Catharina; Wünsch, Viktor A; Bauer, Marcus; Hardel, Tim T; Grensemann, Jörn.

in: CAN J ANESTH, Jahrgang 70, Nr. 9, 09.2023, S. 1486-1494.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Petzoldt, M, Grün, C, Wünsch, VA, Bauer, M, Hardel, TT & Grensemann, J 2023, 'Vie Scope® versus videolaryngoscopy in expected difficult airways: a randomized controlled trial', CAN J ANESTH, Jg. 70, Nr. 9, S. 1486-1494. https://doi.org/10.1007/s12630-023-02534-y

APA

Petzoldt, M., Grün, C., Wünsch, V. A., Bauer, M., Hardel, T. T., & Grensemann, J. (2023). Vie Scope® versus videolaryngoscopy in expected difficult airways: a randomized controlled trial. CAN J ANESTH, 70(9), 1486-1494. https://doi.org/10.1007/s12630-023-02534-y

Vancouver

Petzoldt M, Grün C, Wünsch VA, Bauer M, Hardel TT, Grensemann J. Vie Scope® versus videolaryngoscopy in expected difficult airways: a randomized controlled trial. CAN J ANESTH. 2023 Sep;70(9):1486-1494. https://doi.org/10.1007/s12630-023-02534-y

Bibtex

@article{aec03f268da14dfca760a68029b9533e,
title = "Vie Scope{\textregistered} versus videolaryngoscopy in expected difficult airways: a randomized controlled trial",
abstract = "PURPOSE: The management of patients with an anticipated difficult airway remains challenging. We evaluated laryngeal visualization with the recently introduced Vie Scope{\textregistered} as a straight blade laryngoscope consisting of an illuminated tube necessitating bougie-facilitated intubation vs Macintosh videolaryngoscopy.METHODS: We conducted a prospective randomized controlled noninferiority trial. Patients undergoing elective ear, nose, and throat or oral and maxillofacial surgery with an anticipated difficult airway were randomized 1:1 to receive tracheal intubation with the Vie Scope or Macintosh videolaryngoscope (C-MAC{\textregistered}). The primary outcome measure was laryngeal visualization by the percentage of glottis opening (POGO) scale. Secondary outcome measures were the time to successful intubation (TTI) and first-attempt and overall success rates.RESULTS: We included two sets of 29 patients in our analysis. For visualization, the Vie Scope was noninferior to videolaryngoscopy (VL) with mean (standard deviation [SD]) POGO scores of 71 (31)% vs 64 (30)% in the VL group [difference in means, 7 (8)%; 95% confidence interval, -9 to 23; P = 0.38]. Mean (SD) TTI was 125 (129) sec in the Vie Scope and 51 (36) sec in the VL group (difference in means, 75 sec; 95% confidence interval, 25 to 124; P = 0.005). The first-attempt and overall success rates were 22/29 (76%) and 27/29 (93%) in both groups. Two patients per group were switched to a different device. Four accidental esophageal intubations occurred in the Vie Scope group, these were presumably due to bougie misplacement.CONCLUSION: Visualization with the Vie Scope was noninferior to VL in patients with an anticipated difficult airway, but TTI was longer in the Vie Scope group.STUDY REGISTRATION: ClinicalTrials.gov (NCT05044416); registered 5 September 2021.",
author = "Martin Petzoldt and Catharina Gr{\"u}n and W{\"u}nsch, {Viktor A} and Marcus Bauer and Hardel, {Tim T} and J{\"o}rn Grensemann",
note = "{\textcopyright} 2023. The Author(s).",
year = "2023",
month = sep,
doi = "10.1007/s12630-023-02534-y",
language = "English",
volume = "70",
pages = "1486--1494",
journal = "CAN J ANESTH",
issn = "0832-610X",
publisher = "Springer New York",
number = "9",

}

RIS

TY - JOUR

T1 - Vie Scope® versus videolaryngoscopy in expected difficult airways: a randomized controlled trial

AU - Petzoldt, Martin

AU - Grün, Catharina

AU - Wünsch, Viktor A

AU - Bauer, Marcus

AU - Hardel, Tim T

AU - Grensemann, Jörn

N1 - © 2023. The Author(s).

PY - 2023/9

Y1 - 2023/9

N2 - PURPOSE: The management of patients with an anticipated difficult airway remains challenging. We evaluated laryngeal visualization with the recently introduced Vie Scope® as a straight blade laryngoscope consisting of an illuminated tube necessitating bougie-facilitated intubation vs Macintosh videolaryngoscopy.METHODS: We conducted a prospective randomized controlled noninferiority trial. Patients undergoing elective ear, nose, and throat or oral and maxillofacial surgery with an anticipated difficult airway were randomized 1:1 to receive tracheal intubation with the Vie Scope or Macintosh videolaryngoscope (C-MAC®). The primary outcome measure was laryngeal visualization by the percentage of glottis opening (POGO) scale. Secondary outcome measures were the time to successful intubation (TTI) and first-attempt and overall success rates.RESULTS: We included two sets of 29 patients in our analysis. For visualization, the Vie Scope was noninferior to videolaryngoscopy (VL) with mean (standard deviation [SD]) POGO scores of 71 (31)% vs 64 (30)% in the VL group [difference in means, 7 (8)%; 95% confidence interval, -9 to 23; P = 0.38]. Mean (SD) TTI was 125 (129) sec in the Vie Scope and 51 (36) sec in the VL group (difference in means, 75 sec; 95% confidence interval, 25 to 124; P = 0.005). The first-attempt and overall success rates were 22/29 (76%) and 27/29 (93%) in both groups. Two patients per group were switched to a different device. Four accidental esophageal intubations occurred in the Vie Scope group, these were presumably due to bougie misplacement.CONCLUSION: Visualization with the Vie Scope was noninferior to VL in patients with an anticipated difficult airway, but TTI was longer in the Vie Scope group.STUDY REGISTRATION: ClinicalTrials.gov (NCT05044416); registered 5 September 2021.

AB - PURPOSE: The management of patients with an anticipated difficult airway remains challenging. We evaluated laryngeal visualization with the recently introduced Vie Scope® as a straight blade laryngoscope consisting of an illuminated tube necessitating bougie-facilitated intubation vs Macintosh videolaryngoscopy.METHODS: We conducted a prospective randomized controlled noninferiority trial. Patients undergoing elective ear, nose, and throat or oral and maxillofacial surgery with an anticipated difficult airway were randomized 1:1 to receive tracheal intubation with the Vie Scope or Macintosh videolaryngoscope (C-MAC®). The primary outcome measure was laryngeal visualization by the percentage of glottis opening (POGO) scale. Secondary outcome measures were the time to successful intubation (TTI) and first-attempt and overall success rates.RESULTS: We included two sets of 29 patients in our analysis. For visualization, the Vie Scope was noninferior to videolaryngoscopy (VL) with mean (standard deviation [SD]) POGO scores of 71 (31)% vs 64 (30)% in the VL group [difference in means, 7 (8)%; 95% confidence interval, -9 to 23; P = 0.38]. Mean (SD) TTI was 125 (129) sec in the Vie Scope and 51 (36) sec in the VL group (difference in means, 75 sec; 95% confidence interval, 25 to 124; P = 0.005). The first-attempt and overall success rates were 22/29 (76%) and 27/29 (93%) in both groups. Two patients per group were switched to a different device. Four accidental esophageal intubations occurred in the Vie Scope group, these were presumably due to bougie misplacement.CONCLUSION: Visualization with the Vie Scope was noninferior to VL in patients with an anticipated difficult airway, but TTI was longer in the Vie Scope group.STUDY REGISTRATION: ClinicalTrials.gov (NCT05044416); registered 5 September 2021.

U2 - 10.1007/s12630-023-02534-y

DO - 10.1007/s12630-023-02534-y

M3 - SCORING: Journal article

C2 - 37537324

VL - 70

SP - 1486

EP - 1494

JO - CAN J ANESTH

JF - CAN J ANESTH

SN - 0832-610X

IS - 9

ER -